rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

22 Jul,15:29
1350.00
19.05 (1.43%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL
33,994 1,330.95 1,363.45 - 1,315.55 1,409.25 - 748.45 79,096.50
NSE | BSE

Aurobindo Pharma Ltd.

AUROPHARMA

22 Jul,15:29
1350.00
19.20 (1.44%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Aurobindo Pharma Ltd.

BUYSELL
1,403,529 1330.8 1,363.70 - 1,314.45 1,409.90 - 748.05 18,908.48

News for Aurobindo Pharma Ltd.

Aurobindo Pharma...
Aurobindo Pharma Approves Rs 750 Cr Share Buyback
Aurobindo Pharma's board has approved a share buyback plan of up to Rs 750 crore, representing 0.88% of the total paid-up equity share capital. The buyback will be at Rs 1,460 per share.
Jul 18, 2024 14:58
Lupin, Eugia...
Lupin, Eugia Recall Products from US Market: USFDA
Lupin and Eugia, a unit of Aurobindo Pharma, are recalling products from the US market due to manufacturing issues. The USFDA has initiated Class II and Class III recalls for various medications....
Jun 23, 2024 11:22
Aurobindo Pharma...
Aurobindo Pharma Unit Inks Pact with MSD for Biologics Manufacturing
Aurobindo Pharma's TheraNym Biologics has signed a contract with MSD to set up a plant for contract manufacturing operations for biologicals, investing Rs 1,000 crore.
May 31, 2024 20:45
Aurobindo Pharma Q4 Net Profit Up 79.6% to Rs 909 Cr
Aurobindo Pharma's net profit surged 79.6% to Rs 909 crore in the March quarter, driven by strong revenue growth. Read more about the company's financial performance.
May 25, 2024 21:01
Dr Reddy's, Sun...
Dr Reddy's, Sun Pharma, Aurobindo Recall Products in US
Dr Reddy's, Sun Pharma, and Aurobindo Pharma are recalling products in the US market due to manufacturing issues, according to the latest USFDA Enforcement Report. The recalls include medications...
May 19, 2024 11:13

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia

News for Pharmaceuticals and health care

BigBloc...
BigBloc Construction Approves 1:1 Bonus Share Issue
BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...
Jul 22, 2024 15:32
Stallion India...
Stallion India IPO: Sebi Approves Fundraise
Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.
Jul 22, 2024 15:31
CRR Cut to Help...
CRR Cut to Help Banks Facing Low Deposit Growth: SBI MD
SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...
Jul 22, 2024 15:26
GST Reduces...
GST Reduces Logistics Cost: Economic Survey
India's Economic Survey highlights GST's role in reducing logistics costs, improving truck travel time, and boosting manufacturing. Learn about the impact on logistics performance and India's...
Jul 22, 2024 15:19
Economic Survey:...
Economic Survey: Remove Food From Inflation Targeting
India's Economic Survey suggests removing food from the inflation-targeting framework, arguing that higher food prices are often supply-induced. It proposes using coupons or direct cash transfers...
Jul 22, 2024 15:08

More News »

Top News

BigBloc...
BigBloc Construction Approves 1:1 Bonus Share Issue
BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...
Jul 22, 2024 15:32
Stallion India...
Stallion India IPO: Sebi Approves Fundraise
Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.
Jul 22, 2024 15:31
India's R&D Spending Lags Behind China, US: Eco Survey
India's R&D investment as a percentage of GDP remains low compared to China and the US, with private sector contribution also lagging, according to the Economic Survey 2023-24.
Jul 22, 2024 15:27
CRR Cut to Help...
CRR Cut to Help Banks Facing Low Deposit Growth: SBI MD
SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...
Jul 22, 2024 15:26
Retail Investor Surge in Stock Market: Economic Survey Cautions
India's Economic Survey warns of risks from rising retail investor participation in the stock market, highlighting potential for overconfidence and speculation. Read more.
Jul 22, 2024 15:23

More Top News »

Report Card

PE Ratios
39.91
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,894.03
Face Value (Rs.)
1
Net Profit Margin (%)
9.61
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
6.86

BSE Announcements from Aurobindo Pharma Ltd. (See all)

announcement Intimation Of Record Date For Buyback - 4 day(s) ago
announcement Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors - 4 day(s) ago

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I have invested 10L in Mutual Fund through Lumpsum...

I have hdfc small cap, multicap, flexicap funds all...

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

Hello Sir,I am 44 yrs. My Salary is 3.5lpm. Flat...

Sir, how to find CFP who are genuine, as we had...

I am 50 year old retired person.I have fd of 2 cr...

More REDIFFGURUS

RediffGurus

Money question

Hello Col.I am 34 years old, monthly salary is 1...

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Aurobindo Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close